Contract development and manufacturing organization (CDMO) Cambrex is being purchased by private-equity firm Permira Funds. The $2.4 billion transaction, expected to close during fourth-quarter 2019, is just another deal in the Pharma-Bio Industry's ongoing merger & acquisition spree.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
